Skip to main content
IRWD logo

IRWD · Ironwood Pharmaceuticals Inc · Analyst Estimates

Track IRWD — free
$3.64 -0.12 (-3.19%) At close · Oct 2
Market Cap
$682.44M
Shares
165.24M
Volume · Oct 2 2.7M Avg daily vol (3M) 2.12M

Analyst Estimates

Compare analyst forecasts for Ironwood Pharmaceuticals Inc across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 19:50 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.2
1.21
1.22
—
1.21
1.09
1.21
1.09
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
466600000
471433330
475500000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
1.25
1.5
1.82
—
1.5
1.44
1.5
1.44
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
470300000
494050000
508400000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.3
0.31
0.32
—
0.31
0.29
0.31
0.29
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
120400000
121566670
122300000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
0.34
0.34
0.34
—
0.39333
0.285
0.39333
0.285
— — — —
EPS
analysts
Publication date not stated
— — —
2
— — — —
0
0
1
1
Revenue
USD
Publication date not stated
122000000
128250000
134000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1446847 CUSIP 46333X108 13F (30d) 4 filings 4 filers Visit website Investor relations